U.S. Markets close in 3 hrs 40 mins
  • S&P 500

    4,107.42
    -29.06 (-0.70%)
     
  • Dow 30

    33,811.42
    -114.59 (-0.34%)
     
  • Nasdaq

    11,902.60
    -104.36 (-0.87%)
     
  • Russell 2000

    1,960.41
    -25.13 (-1.27%)
     
  • Crude Oil

    73.79
    +0.40 (+0.55%)
     
  • Gold

    1,879.00
    +2.40 (+0.13%)
     
  • Silver

    22.25
    -0.15 (-0.67%)
     
  • EUR/USD

    1.0722
    -0.0075 (-0.6969%)
     
  • 10-Yr Bond

    3.6320
    +0.1000 (+2.83%)
     
  • Vix

    19.51
    +1.18 (+6.44%)
     
  • GBP/USD

    1.2014
    -0.0043 (-0.3556%)
     
  • USD/JPY

    132.8290
    +1.6790 (+1.2802%)
     
  • BTC-USD

    23,004.90
    -24.94 (-0.11%)
     
  • CMC Crypto 200

    528.81
    +3.67 (+0.70%)
     
  • FTSE 100

    7,836.71
    -65.09 (-0.82%)
     
  • Nikkei 225

    27,693.65
    +184.19 (+0.67%)
     

Moderna Stock: Buy, Sell, or Hold in 2023?

Moderna Stock: Buy, Sell, or Hold in 2023?

Moderna (NASDAQ: MRNA) shares delivered top returns to investors in the earlier days of the pandemic. This year, though, the stock is heading for a 30% loss, even though Moderna's coronavirus vaccine generates billions in revenue and profit. Looking ahead to 2023, you might be wondering whether Moderna's best days are in the past -- or if this vaccine maker still presents an opportunity.